London, United Kingdom

Benjamin Owen Draper

This inventor holds 5 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: King's College London. Active years: 2020-2025.

USPTO Granted Patents = 5 

% Patents Active = 100.0


 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Benjamin Owen Draper

Introduction

Benjamin Owen Draper is a notable inventor based in London, GB. He has made significant contributions to the field of therapeutic agents, holding a total of 5 patents. His work focuses on immunoresponsive cells, particularly T-cells, which have promising applications in therapy.

Latest Patents

One of Draper's latest patents involves therapeutic agents that utilize an immunoresponsive cell, such as a T-cell expressing parallel chimeric activating receptors (pCAR). This innovative arrangement allows for the development of cells that are useful in therapy. The patent also describes kits and methods for using these cells, as well as methods for preparing them.

Career Highlights

Draper is affiliated with King's College London, where he continues to advance his research and innovation in the field of immunotherapy. His work has garnered attention for its potential to improve therapeutic outcomes for various medical conditions.

Collaborations

Draper collaborates with esteemed colleagues, including John Maher and Daniela Yordanova Achkova, who contribute to his research endeavors and help drive innovation in therapeutic applications.

Conclusion

Benjamin Owen Draper exemplifies the spirit of innovation in the field of therapeutic agents. His contributions, particularly in the area of immunoresponsive cells, highlight the importance of research and collaboration in advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…